The Inceptiv spinal cord stimulation system. [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord ...

Multiple FDA-approved SCS systems, such as Nevro’s Senza and HFX iQ, as well as Medtronic’s Vanta, Intellis, and Inceptiv systems are available, each offering different features to cater to individual ...

Medtronic has shared more clinical data on its closed-loop spinal cord stimulation (SCS) system, called Inceptiv, linking the device to sustained improvements across 12 months of treatment.

[Image courtesy of the company] Kuros Biosciences USA recently announced a strategic five-year, exclusive sales agency agreement with Medtronic ... enables stem cell stimulation to form new ...

SAN FRANCISCO—While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now received a European approval for what it describes as ...

“Case outcomes (settlement, plaintiff or defendant ruling) did not statistically vary based on the SCS (spinal cord stimulator) manufacturer type-St. Jude, Boston Scientific Corp., or Medtronic.

Kuros Biosciences USA, Inc., a wholly owned subsidiary of Kuros Biosciences AG, has entered into a five-year, exclusive sales agency agreement with the Medtronic spinal division. Kuros is a ...

Medtronic has received CE marks under the European Union’s Medical Device Regulation (EU MDR) for the BrainSense adaptive deep brain stimulation (aDBS) system and electrode identifier (EI ...

In April, a global leader in healthcare technology, announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv closed-loop rechargeable spinal cord stimulator (SCS) for the ...